David E. Goldgar

Oral Contraceptives and Breast Cancer Risk in the International <i>BRCA1/2</i> Carrier Cohort Study: A Report From EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group

Richard M. Brohet, David E. Goldgar, Douglas F. Easton et al. · Journal of Clinical Oncology · 2007 · 141 citations

Medicine, Gynecology, Oncology +16

Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study

Lieske H. Schrijver, Antonis C Antoniou, Håkan Olsson et al. · American Journal of Obstetrics and Gynecology · 2021 · 62 citations · Full text

Medicine, Gynecology, Oncology +17

Common <i>BRCA2</i> Variants and Modification of Breast and Ovarian Cancer Risk in <i>BRCA1</i> Mutation Carriers

David J. Hughes, Sophie M. Ginolhac, Isabelle Coupier et al. · Cancer Epidemiology Biomarkers & Prevention · 2005 · 14 citations · Full text

Medicine, Genetics, Molecular Genetics +17